10x Genomics, Inc. (TXG)

10x Genomics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,249	1,738	6,615	4,171	16,640	15,237
Market Cap Growth	36.90%	-73.72%	58.59%	-74.93%	9.21%	107.79%
Enterprise Value	1,854	1,426	6,357	3,815	16,120	14,530
Last Close Price	17.77	14.36	55.96	36.44	148.96	141.60
PS Ratio	3.42	2.85	10.69	8.08	33.92	50.99
PB Ratio	2.86	2.45	8.93	5.18	20.35	20.62
P/TBV Ratio	3.14	2.52	9.19	5.36	21.13	21.26
P/OCF Ratio	25.40	260.86	-	-	-	-
EV/Sales Ratio	2.89	2.34	10.27	7.39	32.86	48.62
Debt / Equity Ratio	0.11	0.12	0.13	0.12	0.10	0.09
Asset Turnover	0.65	0.65	0.62	0.50	0.50	0.39
Inventory Turnover	2.56	2.50	2.70	1.70	1.65	2.59
Quick Ratio	3.93	4.09	3.96	4.08	6.10	6.05
Current Ratio	4.48	4.97	4.69	4.85	6.77	6.56
Return on Equity (ROE)	-10.12%	-25.17%	-32.98%	-20.45%	-7.48%	-93.64%
Return on Assets (ROA)	-8.42%	-12.77%	-12.52%	-9.99%	-3.40%	-6.95%
Return on Capital (ROIC)	-9.84%	-14.77%	-14.37%	-11.37%	-3.89%	-8.52%
Return on Capital Employed (ROCE)	-15.00%	-24.00%	-23.80%	-18.20%	-5.80%	-10.50%
Earnings Yield	-3.39%	-10.51%	-3.86%	-3.98%	-0.35%	-3.56%
FCF Yield	3.63%	-0.33%	-0.96%	-3.96%	-0.74%	-1.67%
Buyback Yield / Dilution	-3.07%	-2.80%	-2.90%	-3.18%	-9.09%	-158.76%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q